Skip to main content


Figure 6 | Molecular Cancer

Figure 6

From: Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma

Figure 6

Antitumor effects of sorafenib and MI-319 on A375 melanoma xenografts. (A). Growth curves of A375 xenografts from mice treated with control vehicle (C), sorafenib (S), MI-319 (M), or both drugs (MS). Data is presented as tumor volume relative to tumor volume when treatment started. (B). Western blot analyses of whole tumor lysates prepared from tumors excised on day 21.

Back to article page